ENeura

At eNeura, we are dedicated to pioneering transformative solutions in healthcare.

Join us on a journey into the realm of groundbreaking medical advancements utilizing Transcranial Magnetic Stimulation (TMS) technologies and treatments.

11/12/2025

𝗖𝗼𝘂𝗹𝗱 𝗯𝗲𝘁𝘁𝗲𝗿 𝘀𝗹𝗲𝗲𝗽 𝗯𝗲 𝗮𝗻 𝗮𝗹𝗹𝘆 𝗶𝗻 𝗺𝗶𝗴𝗿𝗮𝗶𝗻𝗲 𝗺𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁? 🧠✨

Reviewing a May 2025 paper on repetitive TMS (rTMS) for insomnia has sparked some ideas. (Source: https://lnkd.in/eBmH2xiQ)

Key findings from the study:

- rTMS increased sleep duration and reduced nighttime arousals

- These changes tracked with improved glymphatic clearance (brain’s waste-removal system)

- Sleep benefits were independent of mood changes: strictly neurophysiological

While this particular study used high-frequency rTMS over the DLPFC, sTMS migraine treatment protocols deliver single pulses to the occipital cortex to calm neural hyperexcitability. The shared mechanism, central neuromodulation, raises a fascinating “what if”:

Could targeting the occipital cortex with electromagnetic pulses help to quiet sleep-disrupting triggers in migraineurs if we know that migraine & poor sleep are bidirectional and glymphatic stagnation can fuel neuroinflammation?

No direct sTMS sleep data yet. But for those of us obsessed with neuromodulation’s potential, this is the kind of information that keeps curiosity and motivation high.

11/11/2025

Happy Veterans Day!
Huge thank you to all who’ve served and continue to serve. We appreciate you today and every day. ❤️

11/10/2025

Key findings in this September study:

(https://lnkd.in/exiX_SSM)

🔬 𝗘𝘅𝗽𝗹𝗼𝗿𝗶𝗻𝗴 𝘁𝗵𝗲 𝗚𝗹𝘂𝘁𝗮𝗺𝗮𝘁𝗲 𝗟𝗶𝗻𝗸 𝗶𝗻 𝗠𝗶𝗴𝗿𝗮𝗶𝗻𝗲 𝗮𝗻𝗱 𝗪𝗵𝘆 𝗖𝗲𝗻𝘁𝗿𝗮𝗹 𝗡𝗲𝘂𝗿𝗼𝗺𝗼𝗱𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗠𝗮𝘁𝘁𝗲𝗿𝘀

This paper addressed the potential role of glutamatergic dysfunction in migraine, and it reinforces something we’re focused on in the neuromodulation world: migraine is not just a vascular headache, it's ultimately a disorder of neuroexcitability and dysregulated neurotransmission. (Source: https://lnkd.in/ex4JU8Da)

Here are 3 take-aways:

• Elevated glutamate levels have been seen in the cortex of migraine sufferers even between attacks, suggesting an underlying state of cortical hyperexcitability.

• Glutamate plays a central role in several migraine-relevant mechanisms: activation via the trigeminovascular system, cortical spreading depression (CSD), and central sensitization.

• Traditional treatments largely act downstream. Targeting this glutamatergic “upstream” process may offer a unique pathway.

𝗦𝗼? 𝗛𝗼𝘄 𝗶𝘀 𝘁𝗵𝗶𝘀 𝗰𝗼𝗻𝗻𝗲𝗰𝘁𝗲𝗱 𝘁𝗼 𝗻𝗲𝘂𝗿𝗼𝗺𝗼𝗱𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝘀𝗽𝗲𝗰𝗶𝗳𝗶𝗰𝗮𝗹𝗹𝘆 𝘀𝗧𝗠𝗦?

Single-pulse transcranial magnetic stimulation (sTMS) has shown evidence of modulating this glutamatergic system.

• In experimental models, sTMS suppressed neuronal firing evoked by glutamate in the visual cortex, indicating a direct inhibitory effect on glutamatergic over-activation. (https://lnkd.in/e25J-kVt)

• Neuromodulation appears to rebalance excitatory/inhibitory circuits. (https://lnkd.in/edvAg2HN)

Putting this together: if migraine patients are already operating from a baseline of heightened states, sTMS provides a “top-down” treatment to address that excitability. Not merely targeting the downstream effects like pain.

Using sTMS technology to target this glutamate-driven excitability aligns perfectly with a “Top-Down” approach for patient care. It supports how central neuromodulation acts on the neurophysiology of the migraine disorder and not merely the headache episode.

Learn more about sTMS at: https://eneura.com/

11/09/2025

💡 Did you know that migraines can be treated without medication?

The eNeura sTMS uses gentle magnetic pulses to stop or prevent migraine attacks.

It’s FDA-cleared and designed for both acute and preventive use in adults and teens (12+).

Check out our website to learn more! 🔗https://eneura.com/

11/08/2025

Learn more at our website! 🔗https://eneura.com/

11/07/2025

Take back your days with eNeura!🧠💙
🔗https://eneura.com/

11/02/2025

🧠 𝗠𝗶𝗴𝗿𝗮𝗶𝗻𝗲 𝗶𝘀 𝗽𝗿𝗼𝗴𝗿𝗲𝘀𝘀𝗶𝘃𝗲 𝗻𝗲𝘂𝗿𝗼𝗹𝗼𝗴𝗶𝗰 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝘁𝗵𝗮𝘁 𝗱𝗲𝘀𝗲𝗿𝘃𝗲𝘀 𝗲𝗮𝗿𝗹𝘆 𝗿𝗲𝗰𝗼𝗴𝗻𝗶𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗶𝗻𝘁𝗲𝗿𝘃𝗲𝗻𝘁𝗶𝗼𝗻.🧠

Another clinical paper pointing out what many already see in clinic: migraine can evolve over time, increasing in frequency, severity, and disability if left untreated. Many children with episodic migraine may progress to more frequent or chronic forms, often with greater functional impairment as they age.

Clinicians are now diagnosing more children (12+ years) with migraine than ever before. Data suggests a prevalence of 8–12% that rises throughout adolescence. (Source: https://lnkd.in/eZuzdqCE)

𝗖𝗮𝗻 𝘄𝗲 𝗮𝗰𝘁 𝗲𝗮𝗿𝗹𝗶𝗲𝗿?

✅ Early intervention matters. Waiting until migraine becomes frequent or disabling allows progression or 'chronification'.

✅ Central Neuromodulation deserves consideration earlier in care. Single-pulse transcranial magnetic stimulation (sTMS) provides a non-invasive, drug-free option that can intervene early in the disease trajectory by targeting the underlying neural dysfunction.

✅ Combining early diagnosis and innovative tools like sTMS may help reduce the impact to a child's (ages 12+) quality of life.

Imagine if it all moved from reactive to proactive migraine care. What does that look like?

Identifying the child with occasional migraine today could help prevent chronic migraine tomorrow.
🔗https://eneura.com/

11/01/2025

This is amazing!🧠
Check out our website to learn more: https://eneura.com/

11/01/2025

For veterans like him, migraines and PTSD go hand in hand. It's time for real solutions. He served his country and now Eneura is helping him reclaim his peace. Thank you for your service. 🇺🇸

10/31/2025

🧠 𝗪𝗵𝘆 𝗱𝗼𝗲𝘀 𝘀𝘁𝗶𝗴𝗺𝗮 𝗿𝗲𝗺𝗮𝗶𝗻 𝘀𝗼 𝗵𝗶𝗴𝗵 𝗳𝗼𝗿 𝗽𝗲𝗼𝗽𝗹𝗲 𝗹𝗶𝘃𝗶𝗻𝗴 𝘄𝗶𝘁𝗵 𝗺𝗶𝗴𝗿𝗮𝗶𝗻𝗲 𝗮𝗻𝗱 𝗵𝗼𝘄 𝗱𝗼𝗲𝘀 𝗺𝗲𝗱𝗶𝗮 𝗽𝗹𝗮𝘆 𝗮 𝗿𝗼𝗹𝗲?

A recent analysis in Headache: The Journal of Head and Face Pain reviewed more than 1.3 million media articles (1998–2017) to see how often “headache” and “migraine” were used metaphorically versus medically.
(Source: https://lnkd.in/eXknWe67)

Nearly half of all references to “headache” were metaphorical. (Example: “this policy is a headache.”)

When “headache” is used as shorthand for annoyance/inconvenience, it shapes public understanding. To what effect? Migraine, a disabling neurological disease, is trivialized.

Language defines perception, and perception defines empathy. When we normalize expressions like “political migraine” or “logistical headache,” it suggests that these conditions are exaggerations, not medical realities.

This misperception 100% drives public stigma and a cycle where patients feel targeted. When migraine is portrayed as mild or metaphorical, the public absorbs that bias. Employers, clinicians, and even friends will underestimate its impact.

𝗧𝗵𝗲 𝗰𝗼𝗻𝘀𝗲𝗾𝘂𝗲𝗻𝗰𝗲? 𝗠𝗮𝗻𝘆 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗶𝗻𝘁𝗲𝗿𝗻𝗮𝗹𝗶𝘇𝗲 𝘁𝗵𝗮𝘁 𝘀𝘁𝗶𝗴𝗺𝗮, 𝗳𝗲𝗲𝗹𝗶𝗻𝗴 𝗮𝘀𝗵𝗮𝗺𝗲𝗱 𝘁𝗼 𝗱𝗶𝘀𝗰𝘂𝘀𝘀 𝘁𝗵𝗲𝗶𝗿 𝗰𝗼𝗻𝗱𝗶𝘁𝗶𝗼𝗻 𝗼𝗿 𝘀𝗲𝗲𝗸 𝗵𝗲𝗹𝗽 𝗯𝗲𝗰𝗮𝘂𝘀𝗲 𝘁𝗵𝗲𝘆 𝗳𝗲𝗮𝗿 𝗯𝗲𝗶𝗻𝗴 𝗱𝗶𝘀𝗺𝗶𝘀𝘀𝗲𝗱 𝗮𝘀 𝘄𝗲𝗮𝗸 𝗼𝗿 𝘂𝗻𝗿𝗲𝗹𝗶𝗮𝗯𝗹𝗲.

Even eNeura's device, SAVI Dual sTMS Migraine Therapy, was intentionally designed not to look like a medical device. Patients can quickly deliver 4 electromagnetic pulses in privacy, allowing someone to maintain confidentiality. Don't underestimate the significance of that for someone trying to not draw attention to themselves.

Check out our website to learn more! https://eneura.com/

10/30/2025

Learn more aout eNeura!
🔗https://eneura.com/

10/29/2025

𝗡𝗲𝘂𝗿𝗼𝗺𝗼𝗱𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝗲𝘀 𝘁𝗼 𝗽𝗿𝗼𝘃𝗲 𝗶𝘁𝘀 𝘃𝗮𝗹𝘂𝗲 𝗶𝗻 𝗺𝗶𝗴𝗿𝗮𝗶𝗻𝗲 𝗰𝗮𝗿𝗲.

A new Cephalalgia study looked at patients with chronic migraine who didn’t respond to anti-CGRP medications. It found that Transcranial Magnetic Stimulation (TMS) helped reduce monthly headache days, cut down on medication use, and even improved mood and cognitive function.
(Source: https://lnkd.in/e2MCSuue)

While this particular study used a different TMS protocol than eNeura's sTMS (Single-Pulse TMS) therapy with SAVI Dual, it does reinforce that the future of migraine treatment is in neurotechnology.

We get to see the difference sTMS makes each day for veterans and migraine patients, so it’s encouraging to see research validating what we’re witnessing firsthand: 𝘄𝗵𝗲𝗻 𝘄𝗲 𝘁𝗮𝗿𝗴𝗲𝘁 𝘁𝗵𝗲 𝗯𝗿𝗮𝗶𝗻 𝗱𝗶𝗿𝗲𝗰𝘁𝗹𝘆, 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗰𝗮𝗻 𝗶𝗺𝗽𝗿𝗼𝘃𝗲.
Visit our website:https://eneura.com/

Address

101 West Dickman Street Suite 900
Baltimore, MD
21230

Website

https://www.eneura.com/get-savi-dual/

Alerts

Be the first to know and let us send you an email when ENeura posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to ENeura:

Shortcuts

Want your practice to be the top-listed Clinic in Baltimore?

ENeura

11/12/2025

11/11/2025

11/10/2025

11/09/2025

11/08/2025

11/07/2025

11/02/2025

11/01/2025

11/01/2025

10/31/2025

10/30/2025

10/29/2025

Address

Website

Alerts

Contact The Practice

Shortcuts

Share

Category